Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Shipments Into U.S. Could Depend On Facility Inspection; FDA Mulls Import Alerts

Executive Summary

Foreign drug manufacturers may face refusal of their products at the U.S. border if they do not submit to an FDA inspection, another part of the agency’s growing effort to increase oversight of the global marketplace.
Advertisement

Related Content

U.S. FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model
FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model
FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model
Establishment Fees Protect American Manufacturing, Mylan Argues In User Fee Proposal
Establishment Fees Protect American Manufacturing, Mylan Argues In User Fee Proposal
Amphastar Lawsuit Over Heparin Shipments Suggests Lovenox ANDA Approval May Be Far Off
Rx Manufacturing Safety Bill Resurfaces Without Inspection Fees
FDA And EMA Revising GMP Rules To Address Supply Chain Deficiencies
FDA And EMA Revising GMP Rules To Address Supply Chain Deficiencies

Topics

Advertisement
UsernamePublicRestriction

Register

PS052851

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel